Otherwise, click the INSTALL button below to install the Sigla 3.3 client and run the application.
If you require assistance with the installation, or would like more information about the software, please contact Mentis Cura
Lewy Body Dementias are difficult to distinguish from Alzheimer’s Disease in the early stages due to overlapping symptoms. A survey of caregivers indicated that 8 out of 10 individuals with Lewy Body Dementias are initially misdiagnosed and half saw 3 or more doctors for more than 10 visits over a period of a year or more before getting an accurate diagnosis. For doctors, one of the concerns is that antipsychotic drugs, which can help Alzheimer’s patients, may have life-threatening side effects for Lewy Body Dementia patients.
Mentis Cura’s Sigla can distinguish Lewy Body Dementias from Alzheimer’s with 84% accuracy. Sigla is a CE marked class 1 medical device in routine use in Iceland and being launched in other European countries.